Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Nymox's fexapotide shows clinically meaningful benefits in BPH

Aug. 31, 2016

Nymox Pharmaceutical announces positive results on fexapotide phase III trial

Aug. 25, 2016

Aurinia reports promising findings from phase IIb study of voclosporin in active lupus nephritis

Aug. 16, 2016

Apricus expands Vitaros agreement with Ferring, terminates agreement with Sandoz

July 27, 2016

Resverlogix begins dosing in phase I study of apabetalone in severe renal impairment

July 22, 2016

FDA accepts Revive's IND for a phase II trial of bucillamine for cystinuria

July 7, 2016

Pfizer introduces AMPK activators

June 22, 2016

FDA approves Rayaldee for secondary hyperparathyroidism in CKD

June 21, 2016

Boehringer Ingelheim discloses aldosterone synthase inhibitors

June 20, 2016

Astellas Pharma and Kotobuki Pharmaceutical patent leucyl-cystinyl aminopeptidase antagonists

June 17, 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...